SERT and NET polymorphisms, temperament and antidepressant response

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Genetic variations in norepinephrine transporter (NET) and serotonin transporter (SERT) genes influence personality, psychiatric disorders, and antidepressant efficacy.
• Investigating these genetic polymorphisms is crucial for understanding treatment response and individual differences in mood disorders.

Purpose of the Study:

• To examine the individual and interactive effects of NET T-182C and SERT 5-HTTLPR polymorphisms on SSRI treatment response and temperament in major depressive disorder (MDD).
• To assess temperamental traits using the Temperament and Character Inventory (TCI) in relation to these genetic variations.

Main Methods:

• A sample of 97 MDD patients completed the TCI questionnaire at baseline and after 6 weeks of SSRI treatment.
• Temperament scores were analyzed in relation to NET and SERT genotypes before and during antidepressant treatment.

Main Results:

• The SS-genotype of SERT 5-HTTLPR was associated with higher baseline Persistence scores compared to SL- or LL-genotypes.
• A similar, though weaker, association was observed at the endpoint.
• No significant effects of 5-HTTLPR genotypes on other temperament dimensions or overall SSRI treatment response were found.

Conclusions:

• The SS-genotype of SERT 5-HTTLPR is associated with elevated Persistence scores in MDD patients.
• Higher Persistence may represent a less adaptive trait linked to stress recovery, potentially due to less efficient serotonin neurotransmission and behavioral coping mechanisms.